Wheels Up, the revolutionary membership-based private aviation company, officially unveiled the first-ever pink Beechcraft King Air 350i aircraft yesterday evening at the Westchester County Airport in White Plains, New York, in support of Breast Cancer Awareness Month. The event hosted by Kenny Dichter, Founder and CEO of Wheels Up, kicked off the #WheelsUpGoesPink campaign in support of the Company’s ongoing commitment to the Dubin Breast Center of The Tisch Cancer Institute at Mount Sinai in New York City, one of the world’s most renowned and advanced facilities for breast cancer treatment and research.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7628751-wheels-up-pink-plane/
Globally renowned tennis champion and Supergoop! Co-Owner Maria Sharapova alongside Supergoop! Founder & CEO Holly Thaggard, are proud to announce the launch of Project Black Dot, a new education and activism platform with the singular mission to end the epidemic of skin cancer and improve skin health in America. Maria is the face and champion of this multidimensional platform that focuses on providing consumers with suncare education and activations year round, not just during the traditional “sun” months.
The Project Black Dot platform, which will unveil multiple initiatives throughout the coming year, will kick off today with “Project 1: Permission,” calling attention to current regulations on sunscreen in schools. This initiative will put the power into the hands of parents and schools by providing a simple, sunscreen permission slip which gives children the ability to use and apply sunscreen at school with the goal of obtaining 100,000 signed sunscreen permission slips.
To view the multimedia release go to:
http://www.multivu.com/players/English/7633051-supergoop-project-black-dot/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
NFL PLAY 60, the National Football League’s youth health and fitness campaign, is the new “Official Champion of Play” at St. Jude Children’s Research Hospital®, the global leader in finding cures and saving children with cancer and other deadly diseases.
To commemorate this new milestone in the ongoing partnership between the NFL and St. Jude, a St. Jude patient will join NFL commissioner Roger Goodell on stage to announce a pick during the first round of the 2013 NFL Draft. The NFL Network and ESPN will televise live coverage of the NFL Draft beginning at 8 p.m. EST on Thursday, April 25.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58566-st-jude-children-s-research-hospital-nfl-play-60
New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists’ annual scientific and education meeting, CAP’14—THE Pathologists’ Meeting, Sept. 7-10 at the Hyatt Regency in Chicago.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7270051-college-of-american-pathologists-cap-14-what-s-next-in-cancer-testing/
Bayer, the maker of Coppertone®, is revolutionizing the sunscreen experience this season with new Coppertone® Whipped, a transformative sunscreen unlike anything you’ve ever felt before. Not only is Coppertone introducing the first ever whipped sunscreen, it is rolling out a series of engaging activations throughout the summer to launch it, and partnering with everyone from beauty influencers to the Skin Cancer Foundation.
The Whipped line, available in both CLEARLYSheer® and WaterBABIES® Pure & Simple formulas, transforms the sunscreen application process from an ordinary task to an experience people can look forward to before they head out into the sunshine. While many other sunscreen lotions can feel heavy or sticky, Whipped has a rich and creamy texture, yet it absorbs quickly and feels light on skin. Plus it won't clog pores and leaves skin feeling soft and smooth while helping to protect it from the sun's harmful UV rays.
To view the multimedia release go to:
https://www.multivu.com/players/English/8113551-coppertone-sunscreen-clearlysheer-whipped/
During a live global event, Elekta announced the launch of Versa HD™, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. Featuring high precision beam shaping and tumor targeting, Versa HD also unveils new capabilities designed to maximize health care system resources and deliver highly sophisticated therapies without compromising treatment times.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60246-elekta-sets-new-benchmark-for-cancer-treatment-launch-of-versa-hd-system
LUNGevity, the nation’s leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably more manageable. The new Lung Cancer Navigator mobile app provides lung cancer patients with access to the latest medical and treatment information related to their specific lung cancer diagnosis, and serves as a convenient hub for organizing customized care and support networks, asking questions, describing and tracking symptoms, and managing multiple medications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7865551-lungevity-lung-cancer-navigator-app/
In the U.S., approximately 159,000 women are living with metastatic breast cancer. To raise awareness of Metastatic Breast Cancer Awareness Day on October 13, MedImmune Specialty Care Division of AstraZeneca (NYSE: AZN) is launching the My+Story online resource center, which highlights the needs of women living with metastatic breast cancer and calls attention to metastatic disease as a key component of October’s National Breast Cancer Awareness Month. Metastatic Breast Cancer Awareness Day was officially recognized by the U.S. Congress in 2009, following a grassroots awareness effort led by members of the Metastatic Breast Cancer Network (MBCN).
To view Multimedia News Release, go to http://www.multivu.com/mnr/63080-astrazeneca-metastatic-breast-cancer-awareness
Many people think being on hospice means lying in a bed, barely conscious. However, this perception is not an accurate one. Many hospice patients' final moments are spent enjoying quality time with family and friends and creating special moments and memories. This would not be possible without the help of hospice.
The mission of hospice is to provide specialized care for patients in the final weeks and months of life and their families. More simply, hospice care supports living one’s life to the fullest with dignity regardless of how much time remains.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances.
Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LLS is committed to funding and recognizing female scientists, physicians, social workers and nurses, and encouraging young women to participate in STEM (science, technology, engineering and math) education and pursue careers in the sciences.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128552-lls-women-in-science/
The Light of Life Foundation, ThyCa: Thyroid Cancer Survivors’ Association, Inc., and Eisai Inc. today announced the launch of Myths and Truths About Thyroid Cancer, an interactive, educational campaign designed to help dispel the myth that thyroid cancer is a “good cancer.” Because most thyroid cancers can be successfully treated, many are told if you are going to get cancer, thyroid cancer is the one to have, which has led to this misperception. However, whether successfully treated or not, the truth is all cancers can have a significant impact on a person’s life, beginning with the shock and distress of hearing the word “cancer” at diagnosis. In honor of Thyroid Cancer Awareness Month and the tens of thousands who receive a thyroid cancer diagnosis each year, Myths and Truths About Thyroid Cancer illustrates the life-changing realities of this disease.
“As a thyroid cancer survivor, I urge people to stop referring to thyroid cancer as the ‘good cancer,’ as I believe it downplays patients’ experiences,” said Joan Shey, founder of the Light of Life Foundation. “I hear time and time again from patients how difficult their diagnosis and treatment were and that their scars are more than skin deep. My hope is that this campaign can educate about the many types of thyroid cancer and change the thyroid cancer conversation.”
“Being part of a community of survivors is very important for people coping with thyroid cancer,” said Gary Bloom, thyroid cancer survivor and co-founder and executive director of ThyCa: Thyroid Cancer Survivors’ Association. “ThyCa takes this to heart, which is why we are proud to provide support and resources to the thyroid cancer community. We also know more needs to be done to elevate awareness of thyroid cancer and what patients need in terms of support for the rest of our lives.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7595951-eisai-thyroid-cancer-myths/
